Balloon system and methods for treating obesity

• US 9,668,900 B2
• Filed: 05/23/2014
• Issued: 06/06/2017
• Est. Priority Date: 05/09/2002
• Status: Expired due to Term

• Current Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Original Assignee: Reshape Medical, Inc. (ReShape LifeSciences, Inc.)
• Inventors: Alverdy, John C.
• Primary Examiner(s): SZPIRA, JULIE ANN
• Application Number:
  US14/286,847
• Publication Number:
  US 20140257358A1
• Time in Patent Office: 1,110 Days
• Field of Search: 606192, 606159, 606191, 604 9601, 604909, 623 2365, 623 2367
• CPC Class Codes: A61F 5/003 inflatable
• CPC Class Codes: A61F 5/004 remotely adjustable

Abstract

A medical system for the treatment of morbid obesity comprising an inflatable balloon implanted in a gastric cavity, a percutaneous fillant delivery tube and a control module connected to the tube for regulating the inflation and deflation of the balloon. The balloon may be individually contoured and inflated to occupy a large volume of the gastric cavity to provide a feeling of satiety. The balloon may also be deflated to give the gastric cavity lining a rest during less critical time.

Claims

1. A gastric device, comprising:

an inflatable balloon, wherein the inflatable balloon is sized to make contact with a portion of a wall of a stomach of a human patient when the balloon is in an inflated state such that an outer surface of the balloon is configured to contact an inner surface of the wall;

a fillant delivery tube extending through the inflatable balloon, wherein a proximal outer surface of the fillant delivery tube is directly connected to a first portion of the inflatable balloon and a distal outer surface of the fillant delivery tube is directly connected to a second portion of the inflatable balloon spaced apart from the first portion; and

a control module for automatically inflating the balloon in the stomach with a biocompatible fillant,

wherein the gastric device is configured to be inflated to a predetermined size with a predetermined volume of the biocompatible fillant.

2. The gastric device of claim 1 wherein the inflatable balloon is further sized to make contact with a major portion of a body of the stomach.

3. The gastric device of claim 1 wherein the control module further comprises a pump configured to introduce the fillant to the balloon.

4. The gastric device of claim 1 wherein the control module further comprises a pump configured to remove the fillant from the balloon.

5. A gastric device, comprising:

an inflatable balloon;

a fillant delivery tube extending through the inflatable balloon, wherein a proximal outer surface of the fillant delivery tube is directly connected to a first portion of the inflatable balloon and a distal outer surface of the fillant delivery tube is directly connected to a second portion of the inflatable balloon spaced apart from the first portion, and wherein a biocompatible fillant is transferred to the inflatable balloon via the fillant delivery tube; and

means for automatically inflating the balloon in a stomach of a human patient with a biocompatible fillant, wherein the gastric device is configured to be inflated to a predetermined size with a predetermined volume of the biocompatible fillant, and

wherein the inflatable balloon is sized to make contact with a portion of a wall of the stomach when the balloon is in an inflated state such that an outer surface of the balloon is configured to contact an inner surface of the wall.

6. The gastric device of claim 5 wherein the balloon is sized to make contact with a major portion of the wall of the stomach when the balloon is in an inflated state.

7. The gastric device of claim 5 wherein the means for automatically inflating the balloon comprises a pump.

8. The gastric device of claim 5 wherein the means for automatically inflating the balloon comprises an external control module, and wherein the external control module is connected to a proximal end of the fillant delivery tube.